Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction is a research paper published in JACC Heart Failure (2020). On theSindex it has a DataRank of 4.9. It has been cited 142 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.744
From this paper's citation signal
Citation Network Contribution
4.2
From 95 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
Gilead Sciences
Novartis
GlaxoSmithKline
Bristol-Myers Squibb
Takeda Pharmaceuticals U.S.A.
American Heart Association
Cytokinetics
National Institutes of Health
Sphingotec GmbH
Amgen
AstraZeneca
Bayer Fund
Medtronic
Merck
National Heart, Lung, and Blood Institute
Roche
Sanofi
MyoKardia
Sanofi Pasteur
MeSH Terms
Keywords